OSUR
Orasure Technologies Inc (OSUR)
Healthcare • NASDAQ • $3.06-2.24%
- Symbol
- OSUR
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $3.06
- Daily Change
- -2.24%
- Market Cap
- $220.21M
- Trailing P/E
- N/A
- Forward P/E
- -6.33
- 52W High
- $3.82
- 52W Low
- $2.08
- Analyst Target
- $5.00
- Dividend Yield
- N/A
- Beta
- 0.89
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORA…
Company websiteResearch OSUR on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.